Table 2.
The guidelines for bowel care and function for people with spina bifida and the citations of supporting evidence
| Age group | Guidelines | Evidence | |
|---|---|---|---|
| 0–11 months | 1. | Monitor stool frequency, consistency, and amounts. | [7, 8, 11] | 
| 2. | Monitor stool frequency, consistency, and amounts. | [8, 11–14, 16, 18] | |
| 3. | Use dietary management, in particular breastfeeding if possible, as breastmilk is easier to digest and offers better restoration of the microbiome after surgery. | [8, 11–14, 16, 18] | |
| 4. | Consider dietary management (fiber and fluids) before pharmacologic adjuncts (sennoside), and/or rectal stimulants (glycerin suppositories) to manage constipation. | [8, 11–14, 16, 18, 23], clinical consensus | |
| 5. | Use barrier creams to protect perineal area from breakdown as needed. | [11, 17, 24], Integument (Skin) Guidelines | |
| 1–2 years | 1. | Discuss toilet training and habit training with parents. | [8, 10–11, 17–18] | 
| 11 months | 2. | Establish goal of working toward bowel continence. | [8, 10–11, 17–18] | 
| 3. | Focus on fiber, fluids, exercise, and timed bowel movements after meals. | [8, 11, 14–15, 18–19] | |
| 4. | Consider two-pronged approach of oral and rectal interventions to meet the goal of bowel continence without constipation. | [8, 11, 14–15, 18–19] | |
| 5. | Use dietary management (fiber and fluids), pharmacologic adjuncts (sennoside, polyethylene glycol), and/or rectal stimulants (glycerin, docusate sodium, or bisacodyl suppositories) to manage constipation and fecal incontinence. | [8, 11, 14–15, 18–19] | |
| 6. | Use barrier creams to protect perineal area from breakdown as needed. | [11, 17, 24] Integument (Skin) Guidelines | |
| 7. | Refer to a Spina Bifida clinic or specialist with expertise in bowel management in Spina Bifida. | [8, 10], clinical consensus | |
| 3–5 years 11 months | 1. | Discuss consequences of constipation and bowel incontinence (including shunt malfunction, urinary tract infections (UTIs), skin breakdown, social isolation. | [3–5, 7, 10, 18] | 
| 2. | Establish the goal of bowel continence and institute the bowel continence program using guidelines below. | [3–5, 7, 10, 18] | |
| 3. | Focus on fiber, fluids, exercise, and timed bowel movements after meals. | [8, 11, 14–15, 18–19] | |
| 4. | Consider two-pronged approach of oral and rectal interventions to meet the goal of bowel continence without constipation. | [8, 11, 14–15, 18–19] | |
| 5. | Use dietary management (fiber and fluids), pharmacologic adjuncts (sennoside, polyethylene glycol), and/or rectal stimulants (glycerin, docusate sodium, or bisacodyl suppositories) to manage constipation and fecal incontinence. | [8, 11, 14–15, 18–19] | |
| 6. | Use barrier creams to protect perineal area from breakdown as needed. | [11, 17, 24] Integument (Skin) Guidelines | |
| 7. | Refer to a Spina Bifida clinic or specialist with expertise in bowel management in Spina Bifida. | [8, 10], clinical consensus | |